Early Assessment of Minimal Residual Disease Identifies Patients at Very High Relapse Risk in NPM-ALK-positive Anaplastic Large Cell Lymphoma - Damm-Welk, C; Mussolin, L; Zimmermann, M (Blood, 2014)
et al.